» Articles » PMID: 34712602

MiRNA-146a/AKT/β-Catenin Activation Regulates Cancer Stem Cell Phenotype in Oral Squamous Cell Carcinoma by Targeting CD24

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Oct 29
PMID 34712602
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

CD44CD24 population has been previously reported as cancer stem cells (CSCs) in Oral Squamous Cell Carcinoma (OSCC). Increasing evidence suggests potential involvement of microRNA (miRNA) network in modulation of CSC properties. MiRNAs have thus emerged as crucial players in tumor development and maintenance. However, their role in maintenance of OSCC stem cells remains unclear. Here we report an elevated expression of miR-146a in the CD44CD24 population within OSCC cells and primary HNSCC tumors. Moreover, over-expression of miR-146a results in enhanced stemness phenotype by augmenting the CD44CD24 population. We demonstrate that miR-146a stabilizes β-catenin with concomitant loss of E-cadherin and CD24. Interestingly, CD24 is identified as a novel functional target of miR-146a and ectopic expression of CD24 abrogates miR-146a driven potential CSC phenotype. Mechanistic analysis reveals that higher CD24 levels inhibit AKT phosphorylation leading to β-catenin degradation. Using stably expressing miR-146a/CD24 OSCC cell lines, we also validate that the miR-146a/CD24/AKT loop significantly alters tumorigenic ability . Furthermore, we confirmed that β-catenin trans-activates miR-146a, thereby forming a positive feedback loop contributing to stem cell maintenance. Collectively, our study demonstrates that miR-146a regulates CSCs in OSCC through CD24-AKT-β-catenin axis.

Citing Articles

Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD24.

Liu Y, Ma J, Ma Y, Wang B, Wang Y, Yuan J J Immunother Cancer. 2025; 13(2).

PMID: 40010762 PMC: 11865804. DOI: 10.1136/jitc-2024-010813.


Decoding oral cancer: insights from miRNA expression profiles and their regulatory targets.

Wang X, Zhang S, Wang S, Cao T, Fan H Front Mol Biosci. 2025; 11:1521839.

PMID: 39935706 PMC: 11810738. DOI: 10.3389/fmolb.2024.1521839.


Natural compounds targeting miRNAs: a novel approach in oral cancer therapy.

Doghish Y, Doghish A, Mageed S, Mohammed O, Hamza T, Abdelaziz A Funct Integr Genomics. 2024; 24(6):202.

PMID: 39455476 DOI: 10.1007/s10142-024-01473-1.


Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges.

Acharya S, Shai S, Choon Y, Gunardi I, Hartanto F, Kadir K Biomedicines. 2024; 12(9).

PMID: 39335624 PMC: 11429394. DOI: 10.3390/biomedicines12092111.


Hypomethylation-associated Sox11 upregulation promotes oncogenesis via the PI3K/AKT pathway in OLP-associated OSCC.

Liu Y, Cao P, Xiao L, Tang N, Fei W, Li X J Cell Mol Med. 2024; 28(14):e18556.

PMID: 39039706 PMC: 11263134. DOI: 10.1111/jcmm.18556.


References
1.
Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H . The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011; 17(2):211-5. PMC: 3076220. DOI: 10.1038/nm.2284. View

2.
Zhao J, Starczynowski D . Role of microRNA-146a in normal and malignant hematopoietic stem cell function. Front Genet. 2014; 5:219. PMC: 4087671. DOI: 10.3389/fgene.2014.00219. View

3.
Shi Z, Johnson J, Jiang R, Liu Y, Stack M . Decrease of miR-146a is associated with the aggressiveness of human oral squamous cell carcinoma. Arch Oral Biol. 2015; 60(9):1416-27. PMC: 4536106. DOI: 10.1016/j.archoralbio.2015.06.007. View

4.
Chen D, Wang C . Targeting cancer stem cells in squamous cell carcinoma. Precis Clin Med. 2019; 2(3):152-165. PMC: 6770277. DOI: 10.1093/pcmedi/pbz016. View

5.
Hosonaga M, Arima Y, Sugihara E, Kohno N, Saya H . Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells. Cancer Sci. 2014; 105(7):779-87. PMC: 4317915. DOI: 10.1111/cas.12427. View